Premium
Determining specificities and affinities between BH3 peptides and BcL‐2 proteins using yeast surface display
Author(s) -
Genilo Elyza Joy,
Dutta Sanjib,
Keating Amy
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.894.4
Subject(s) - affinities , receptor , yeast , saccharomyces cerevisiae , biochemistry , apoptosis , biology , microbiology and biotechnology , bcl xl , chemistry , bcl 2 family , cell , protein–protein interaction , programmed cell death
Apoptosis in every cell is determined by protein‐protein interactions between the BcL‐2 family, consisting of two subgroups: anti‐apoptotic proteins (BcL‐2, BcL‐xL, BcL‐W, McL‐1, and A‐1) and pro‐apoptotic proteins. A specific subgroup of the pro‐apoptotic proteins consist of "BH3 only" proteins. Our interest is to examine the specificities and affinities between the anti‐apoptotic and the "BH3 only" proteins. These interactions occur between the amphiphilic regions of the BH3 peptides with the hydrophobic indentations of the BcL‐2 proteins. A pool of BH3 peptides selected for specificity or promiscuity against BcL‐xL or McL‐1 were displayed on yeast cells and tested against several anti‐apoptotic proteins. To understand specificities, the BH3 peptides were tested against these receptors using a high‐throughput approach to determine which peptides were specific or promiscuous to the receptors. To understand affinity, a selected amount of specific BH3 clones were used for quantitative measurement of binding affinity. By observing specificities and versatilities in protein sequences, we can then manipulate the proteins to act as inhibitors or stimulators of favorable cellular outcomes.